Skip to main content

Table 5 Survival outcome of NED and non-NED group

From: The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision

Survival outcome

NED

(n = 41)

Non-NED

(n = 33)

Number of patients followed until death

11 (26.8%)

19 (57.6%)

3-year survival rate

61.8%

29.6%

Median survival time (month)

46

32